Projected clinical and economic benefits of improved patent foramen ovale testing among cryptogenic stroke patients in the United States
Improving PFO diagnostic testing among patients with cryptogenic stroke is projected to result in improved health outcomes for patients, while yielding cost-savings, underscoring the importance of adhering to PFO diagnostic guidelines.
Authors
- Erik J. Landaas (ORCID: https://orcid.org/0000-0002-1871-4963)
- Scott Eric Kasner (ORCID: https://orcid.org/0000-0003-0418-6917)
- Timon Louwsma (ORCID: https://orcid.org/0009-0005-3368-8774)
- Giorgia Tiozzo (ORCID: https://orcid.org/0000-0003-4517-3186)
- Ryan J. Imhoff (ORCID: https://orcid.org/0000-0002-4786-1401)
- John Volpi (ORCID: https://orcid.org/0000-0002-4716-3734)
- Tjeerd Looman
Institutions
- W. L. Gore & Associates (Germany) (DE)
- Houston Methodist (US)
- University Medical Center Groningen (NL)
- Academic Software (United States) (US)
- W. L. Gore & Associates (United States) (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1080/13696998.2025.2535236
- Citations
- 2
- Primary Topic
- Cardiovascular and Diving-Related Complications
- Type
- article
- Field-Weighted Citation Impact
- 3.04